Schedule 13G ownership disclosure
Ampio Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 03209T109
Event date: 2019-06-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,636,535
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-19-002827
- Form type
- SC 13G
- Filer
- Ampio Pharmaceuticals, Inc.
- CIK
- CIK 1411906
- Filed
- Jun 20, 2019
- Reporting period
- Jun 17, 2019
- Description
- Schedule 13G beneficial ownership